Regulatory/Legislative News

The Federal Trade Commission announced in a June 23 press release that updates to the Contact Lens Rule will now mandate that doctors who prescribe contact lenses must maintain proof that they released the prescription to the patient for at least 3 years.

A Supreme Court decision Thursday allowed the Deferred Action for Childhood Arrivals, or DACA, program to remain in effect, keeping the approximately 690,000 offspring of U.S. immigrants from being deported.

A judge in the U.S. Court of Appeals blocked HHS from implementing a rule requiring drug companies to put the manufacturer’s list price for prescription drugs or biological products to wholesalers or direct purchasers in TV commercials.

The HHS announced that it has finalized a rule that allows the government to interpret sex discrimination based on the definition of the word “sex” as male or female and biology — a move the agency also said “protects and enforces the civil rights of all.”

The United States, the United Kingdom, Chile, Germany and Italy have proposed using “immunity passports” as a potential strategy for easing physical distancing measures, according to a paper published in The Lancet. However, a bioethics expert told Healio Primary Care that there are too many barriers for governments to implement them.

CMS recently announced a second round of regulatory waivers and rule changes to expand care to the nation’s seniors and provide health care systems flexibility.

The Affordable Care Act was signed into law 10 years ago today.

Patients will soon have what HHS called “unprecedented” secure and free access to their health information.

SAN FRANCISCO — Ensuring safe and effective products are available to the American people is the mission of the FDA Center for Drug Evaluation and Research, which is why there is a reason behind everything the FDA asks for when studying new drug products, according to a speaker at Glaucoma 360: New Horizons Forum.

The American Optometric Association voiced its concern to Aetna regarding “inappropriate decisions” made on claims submitted by some physicians, including optometrists.